Company / PP&E per Share
Zentalis Pharmaceuticals, Inc. PP&E per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.04
FY2025
5-year range
$0.04 / $0.07
FY2024-FY2025
Trend
-41.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
0.04 in FY2025.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share decreased 41.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | -41.5% |
| FY2024 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026